총 50 건의 최근 내부자 거래 내역가 기록되었습니다 IntelGenx Technologies Corp. (IGXT), 포함 34 건 매수 및 16 건 매도. 내부자 매수 총액은 $2.47M 내부자 매도 총액은 $258.48K.
최근 활동이 있는 주요 내부자에는 Pourhassan Zenoz Nina, Kideckel David, Kalayajian Karen. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — IGXT
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2027-04-04 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
처분 |
6,250 |
$0.19 |
$1.19K |
- |
| 2027-04-04 |
Kideckel David |
SVP, Corp. Dev&sa - Subsidiary |
처분 |
62,500 |
$0.19 |
$11.88K |
- |
| 2027-01-29 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
처분 |
6,250 |
$0.24 |
$1.5K |
- |
| 2026-04-04 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
처분 |
6,250 |
$0.19 |
$1.19K |
- |
| 2025-06-30 |
Gorham Dwight |
CEO |
처분 |
950,000 |
$0.16 |
$152K |
- |
| 2025-04-04 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
처분 |
12,500 |
$0.19 |
$2.38K |
- |
| 2024-04-19 |
Atai Life Sciences N.v. |
10 Percent Owner |
기타 (매수) |
- |
$0.19 |
- |
- |
| 2024-03-08 |
Atai Life Sciences N.v. |
10 Percent Owner |
기타 (매수) |
4,000,000 |
$0.17 |
$680K |
4,000,000 |
| 2024-01-29 |
Zerbe Horst G |
Director |
RSU 부여 |
107,435 |
- |
- |
138,204 |
| 2024-01-29 |
Melchers Bernd Josef |
Director |
RSU 부여 |
111,783 |
- |
- |
111,783 |
| 2024-01-29 |
Godin Andre |
President and CFO |
RSU 부여 |
163,968 |
- |
- |
387,045 |
| 2024-01-29 |
Mayr Clemens |
Director |
RSU 부여 |
92,510 |
- |
- |
111,783 |
| 2024-01-29 |
Paiement Nadine |
VP R & D of Intelgenx Corp. |
RSU 부여 |
96,206 |
- |
- |
136,206 |
| 2024-01-29 |
Nawacki Mark |
Director |
RSU 부여 |
111,783 |
- |
- |
111,783 |
| 2024-01-29 |
Kenny Tommy |
SVP Ip Legal Affairs Subsid |
RSU 부여 |
95,648 |
- |
- |
145,648 |
| 2024-01-29 |
Kalayajian Karen |
VP, Finance & Admin of Subs. |
RSU 부여 |
97,925 |
- |
- |
137,925 |
| 2024-01-29 |
Gorham Dwight |
CEO |
RSU 부여 |
182,186 |
- |
- |
182,186 |
| 2024-01-29 |
Pourhassan Zenoz Nina |
VP, Quality Operations of Subs |
RSU 부여 |
67,682 |
- |
- |
67,682 |
| 2023-12-10 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
처분 |
25,000 |
$0.44 |
$11K |
- |
| 2023-11-28 |
Atai Life Sciences N.v. |
10 Percent Owner |
정보 매수 |
750,000 |
$0.19 |
$138.75K |
2,970,000 |
| 2023-10-06 |
Atai Life Sciences N.v. |
10 Percent Owner |
기타 (매수) |
8,500,000 |
$0.19 |
$1.57M |
8,500,000 |
| 2023-09-30 |
Atai Life Sciences N.v. |
10 Percent Owner |
기타 (매수) |
7,401 |
- |
- |
7,401 |
| 2023-08-31 |
Atai Life Sciences N.v. |
10 Percent Owner |
정보 매수 |
- |
$0.19 |
- |
- |
| 2023-04-13 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
처분 |
40,000 |
- |
- |
- |
| 2023-04-04 |
Godin Andre |
President & CFO |
RSU 부여 |
100,000 |
$0.19 |
$19K |
223,077 |
| 2023-04-04 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
RSU 부여 |
12,500 |
$0.19 |
$2.38K |
262,500 |
| 2023-04-04 |
Kideckel David |
SVP, Corp. Dev&sa - Subsidiary |
처분 |
50,000 |
- |
- |
- |
| 2023-01-29 |
Zerbe Horst G |
Chief Executive Officer |
RSU 부여 |
125,000 |
- |
- |
155,769 |
| 2023-01-29 |
Zerbe Ingrid |
Corporate Secretary |
RSU 부여 |
6,250 |
$0.24 |
$1.5K |
6,250 |
| 2023-01-29 |
Godin Andre |
President & CFO |
RSU 부여 |
100,000 |
- |
- |
123,077 |
| 2023-01-29 |
Paiement Nadine |
VP R & D, Intelgenx Corp. |
RSU 부여 |
40,000 |
- |
- |
40,000 |
| 2023-01-29 |
Matzen Dana |
VP Business & Corp. Dev |
RSU 부여 |
50,000 |
- |
- |
50,000 |
| 2023-01-29 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
RSU 부여 |
50,000 |
- |
- |
50,000 |
| 2023-01-11 |
Kenny Tommy |
VP Ip,lgl Affairs - Subsidiary |
처분 |
37,500 |
$0.27 |
$10.13K |
- |
| 2022-11-24 |
Kalayajian Karen |
VP, Finance&admin - Subsidiary |
처분 |
75,000 |
$0.27 |
$20.25K |
- |
| 2022-11-11 |
Pourhassan Zenoz Nina |
VP, Quality Ops of Subsidiary |
처분 |
55,000 |
$0.27 |
$14.85K |
- |
| 2022-09-30 |
Zerbe Horst G |
Chief Executive Officer |
정보 매수 |
14,000 |
$0.12 |
$1.74K |
368,064 |
| 2022-09-29 |
Godin Andre |
President and CFO |
정보 매수 |
5,000 |
$0.12 |
$620.00 |
308,399 |
| 2022-09-21 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
정보 매수 |
25,000 |
$0.14 |
$3.45K |
75,000 |
| 2022-07-07 |
Zerbe Ingrid |
Corporate Secretary |
기타 (매도) |
100,000 |
$0.22 |
$22K |
- |
| 2022-07-07 |
Godin Andre |
President and CFO |
기타 (매도) |
20,000 |
- |
- |
- |
| 2022-03-30 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
정보 매수 |
25,000 |
$0.27 |
$6.63K |
50,000 |
| 2021-07-11 |
Kenny Tommy |
VP Ip,lgl Affairs - Subsidiary |
처분 |
37,500 |
$0.27 |
$10.13K |
- |
| 2021-06-08 |
Matzen Dana |
VP Bd & Corp.dev.of Subsidiary |
정보 매수 |
10,000 |
$0.48 |
$4.8K |
10,000 |
| 2021-05-14 |
Atai Life Sciences B.v. |
10 Percent Owner |
처분 |
- |
- |
- |
- |
| 2021-04-13 |
Matzen Dana |
VP Bd & Corp Dev of Subsidiary |
정보 매수 |
25,000 |
$0.49 |
$12.23K |
25,000 |
| 2021-04-07 |
Godin Andre |
President and CFO |
정보 매수 |
20,000 |
$0.44 |
$8.8K |
200,171 |
| 2021-04-07 |
Kenny Tommy |
VP Ip Legal Affairs-subsidiary |
정보 매수 |
11,000 |
$0.44 |
$4.84K |
77,000 |
| 2021-04-01 |
Boudreau Bernard |
Director |
정보 매수 |
12,500 |
$0.47 |
$5.86K |
148,000 |
| 2021-03-30 |
Boudreau Bernard |
Director |
정보 매수 |
12,500 |
$0.40 |
$4.95K |
135,500 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
